No risk reduction for Plasmodium vivax malaria in sickle cell disease

1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hemoglobin S is known to protect against uncomplicated Plasmodium falciparum malaria. However, there is paucity of the literature regarding interaction of HbS and other malaria species. Usually, P. vivax malaria is a relapsing condition, and without radical cure with primaquine, recurrence may be observed even with hemoglobin S.

Cite

CITATION STYLE

APA

Moiz, B., & Majeed, A. (2018, June 1). No risk reduction for Plasmodium vivax malaria in sickle cell disease. Clinical Case Reports. Wiley-Blackwell Publishing Ltd. https://doi.org/10.1002/ccr3.1507

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free